The Product Is the Brand: What 2,310 Infused Beverage Shoppers Actually Tell Us About Purchase Decisions
Operator Takeaways from the largest ongoing real-world study of infused beverages
There's a version of the infused beverage industry that exists in pitch decks and investor presentations. It's a world of brand equity, heritage storytelling, lifestyle positioning, and premium price justification built on the back of good creative. The beverages in that world are sold the way craft beer was sold in the 2010s — by making you feel something before you taste anything.
Then there's the version of the industry that exists in the data.
The largest ongoing real-world study of infused beverages has now collected purchase-intent and experience data from thousands of consumers who have actually tried these products — not just seen the ads. The gap between what the industry believes drives purchase decisions and what actually does is not a rounding error. It's a strategic miscalculation that is quietly capping repeat rates for brands that haven't looked at the numbers.
Here's what the data says. And here's what to do about it.
What Actually Drives the Purchase Decision
When 2,310 consumers were asked what matters most when choosing an infused beverage, the results didn't just defy conventional marketing wisdom — they inverted it.
Flavor came in first at 21.3%. Availability — whether the product is in stock or on the menu — was nearly tied at 20.5%. Nutritional facts (calories, sugar content, and similar markers) followed at 19.0%. THC dosage registered at 15.3%. Evidence or data on quality and performance contributed 12.1%. Recommendations from trusted people and price each came in at 5.0%.
And brand reputation or familiarity? 1.8%.
Read that again. In a category where many operators are still pouring meaningful budget into brand-awareness campaigns, brand reputation is essentially statistical noise in the purchase decision. It's not that branding doesn't matter at all — it's that the product experience has become so determinative that brand, in the traditional sense, is downstream of it. If the flavor is wrong, the dose is unpredictable, or the product isn't where the consumer can find it, no amount of brand equity closes the gap.
The practical implication is uncomfortable for anyone who has built a marketing org around traditional CPG playbooks: in this category, right now, the product experience is the brand. Full stop.
The Good News on Taste — and Why It's Incomplete
On taste, the data is largely encouraging. Out of 1,925 respondents who had tried an infused beverage, 81.3% at least agreed they liked the taste. The mode rating was 8 out of 10, and scores between 7 and 10 accounted for roughly 65% of all responses. When asked to describe the taste in a single word, the dominant responses were sweet, fruity, light, delicious, and crisp.
Perhaps most significant for operators worried about cannabis masking: 89.7% of respondents reported zero or only slight cannabis taste. That's not a minor detail. It's one of the most persistent anxieties in product development for this category, and the data suggests that the formulation work is paying off for most products in the field.
But taste alone is not converting the category. That's where the data gets more complicated.
Among the same 1,925 respondents, only 50.3% said they would definitely purchase again. Of that group, 46.9% reported liking the taste — which means that even among definite repurchasers, taste satisfaction was not universal. More critically, 34.9% of respondents were undecided about repurchase. Of that undecided group, 27.1% also reported liking the taste.
Let that sink in. More than a quarter of the undecided group already likes the product. They're not on the fence because of flavor. Something else is holding them back — and that something, when you follow the qualitative feedback, is almost always dose.
The 12.8% who said they wouldn't purchase again are a different story: taste dislike is the leading predictor in that group, accounting for 7.5% of the total. For them, the product experience genuinely failed. But they're not where the growth is. The growth is in that 34.9% who liked what they tasted and still didn't commit.
The Real Friction: Dose Polarization
Across positive, neutral, and negative written reviews from 1,557 respondents, dose is the most consistent source of friction in the category. And it cuts in both directions.
Higher-tolerance users frequently report needing multiple servings to feel anything meaningful. Lower-tolerance users occasionally describe effects they found too intense or unpredictable. The functional sweet spot — where a single serving produces the expected, comfortable experience — is narrower than most product teams assume. And that sweet spot is exactly where repeat purchase lives or dies.
This isn't a labeling problem, though clearer labeling helps. It's a product architecture problem. The category has largely standardized around a single dose format for a consumer population with enormously varying tolerance levels, prior experience, body chemistry, and intentions. What works as an entry point for a first-time consumer is often insufficient for someone with six months of regular use. What's appropriate for a seasoned consumer can be genuinely too much for someone new.
The result is that a meaningful segment of interested, taste-satisfied consumers can't find the dose that works for them — and they don't come back.
Price Isn't What You Think It Is
Price ranked at 5.0% as a stated purchase factor, which would seem to indicate that infused beverage consumers are relatively price-insensitive. The written feedback complicates that picture considerably.
When consumers describe a product as "too expensive," they almost never mean the price point in isolation. They mean the price relative to what they needed to consume to achieve the effect they were looking for. The complaints aren't "this can costs too much." They're "I needed three cans to feel anything — that's not worth it."
This is a meaningful reframe for operators. The sticker price on an infused beverage isn't necessarily wrong. But if a meaningful portion of your consumer base needs to buy multiple units per occasion to achieve the intended effect, you don't have a pricing problem — you have a value-per-dose problem. And it will show up in the data as price sensitivity even when the underlying issue is dose.
The practical intervention isn't discounting. It's multipacks that make dosing to effect more economically accessible, higher-dose SKUs for tolerance-established consumers, and "find your dose" onboarding that helps new users calibrate rather than give up.
Availability Is an Education Problem, Not Just a Distribution Problem
Availability tied with flavor as the top purchase driver at 20.5% — which would already justify significant investment in distribution expansion and on-premise placement. But the written feedback adds a layer that the percentage alone doesn't capture.
Respondents frequently reported thinking these products were illegal in their state. Others said they didn't know where to find them locally. A significant segment had no idea they could order online. These aren't consumers who couldn't find the product on the shelf. These are consumers who never went looking because they didn't know to look.
The implication is that the availability problem in infused beverages is at least partly an awareness problem — and awareness problems can be solved by marketing right now, without waiting for distribution infrastructure to catch up. If your product is available in a consumer's state, city, or zip code, and that consumer doesn't know it, you have a discoverability gap that a targeted digital campaign, SEO strategy, or store-locator investment can address immediately.
The most underutilized insight in this data may be that consumer education about legality, availability, and purchasing channels is itself a form of distribution.
Five Things to Do Differently in 2026
Prioritize product experience over brand-building in your spend. The data is unambiguous: brand reputation accounts for 1.8% of the purchase decision. Flavor accounts for 21.3%. Before you commission the next brand campaign, ask whether that budget would produce more return reinvested in formulation quality, flavor variety, or cannabis taste masking. For most operators in this category at this stage, the answer is yes.
Match your copy to how consumers actually describe the experience. Sweet, fruity, light, crisp — that's the language consumers are using when they describe what they like. If your PDP, ad copy, or packaging leads with botanical, craft, artisanal, or other category-adjacent vocabulary that doesn't match the actual sensory experience, you may be creating an expectations gap that works against you. Use the words your consumers are already using.
Build a tiered dosing architecture. Nearly half the market — the 34.9% undecided plus the 12.8% definite non-repurchasers — isn't converting to a definite repeat purchase. Dose is the primary driver of that gap. A low/standard/strong tiered SKU structure, combined with onboarding content that helps consumers identify where to start, directly addresses the most significant barrier to repeat purchase in the category.
Reframe value around effect, not unit cost. The consumer who says your product is too expensive is almost certainly telling you that the dose-to-effect ratio isn't working for their tolerance level. Multipacks, higher-dose SKUs, and value bundles structured around "find your dose" messaging attack this directly. The goal isn't to lower price — it's to make the pathway to an effective dose more economical and more legible.
Invest in discoverability before distribution. If consumers in states where your product is legally available don't know it's available, you have a marketing problem you can solve today. State-specific digital campaigns that address legality, store locators, and online ordering capabilities are all high-leverage interventions that don't require a single new retailer partnership. Solve the awareness gap while you scale the distribution gap.
The Summary
The infused beverage category is at an inflection point that a lot of operators aren't fully seeing. The product quality is there — taste scores are strong, cannabis masking is working, and the fundamental consumer experience is positive for the majority of people who try these products. The challenge isn't product-market fit in any existential sense.
The challenge is conversion. And the data shows exactly where it's breaking down.
Flavor and availability are carrying the purchase decision. Dose is determining whether a satisfied, taste-positive consumer comes back. Price sensitivity is really a dose-efficiency complaint in disguise. And brand reputation is doing almost none of the work anyone assumed it was doing.
The operators who take the 2026 planning cycle seriously will redirect resources accordingly: less brand building, more formulation investment; less lifestyle messaging, more consumer education; less standard-dose thinking, more tiered product architecture.
In this category, at this moment, the product experience is the brand. Build accordingly.
Recommended
Data sourced from the largest ongoing real-world study of infused beverages. Purchase decision survey N=2,310; taste experience survey N=1,925; review analysis N=1,557.
